A statistical analysis of BRCA1/2 mutation carriers and non-carriers in Chinese Hakka breast cancer patients revealed that family history, bilateral cancer, HER2-, and Ki67 ≥ 15% were significant independent predictors of BRCA1/2 pathogenic variants. Here, ERBB2 is linked to breast carcinoma.